熱門資訊> 正文
Sana Biotechnology通过ATM股票出售筹集6900万美元
2026-05-15 21:26
- Sana Biotechnology (SANA) said on Friday it sold about 21.6M shares through its at-the-market facility with TD Securities, generating net proceeds of roughly $69M.
- The company said the financing, together with a previously announced unrelated $25M investment from the Mayo Clinic, increased total capital raised since the end of the first quarter of 2026 to about $94M.
- Sana said the funding extends its expected cash runway to mid-2027.
- Stock down 4% in premarket trading.
More on Sana Biotechnology
- Sana Biotechnology, Inc. (SANA) Presents at Bank of America Global Healthcare Conference 2026 Transcript
- Sana Biotechnology: Mayo Clinic Deal A Positive Step On A Long Journey
- Sana Biotechnology, Inc. (SANA) Presents at The Citizens Life Sciences Conference 2026 Transcript
- Sana Biotechnology GAAP EPS of -$0.17 in-line
- Sana Biotech rises as Mayo Clinic partners for diabetes therapy
推薦文章
新股申購 | 多光譜AI技術龍頭海清智元今起招股，一手入場費3636.31港元
華盛早報 | 中東戰火重燃！納指跌近2%，伊朗關閉霍爾木茲海峽；黃金已跌去今年所有漲幅；甲骨文績后大跌10%
績后大跌！甲骨文交出靚麗財報，但鉅額融資計劃引擔憂
6月11日外盤頭條：特朗普宣佈立即打擊伊朗 美國5月退還220億美元關税 Anthropic呼籲強制測試AI模型
SpaceX上市倒計時：聚焦史上最大IPO 華爾街熱捧與質疑交織
騰訊AI加速「建群」
美股機會日報 | 警報拉響！納指期貨跳水跌1.6%，特朗普或繼續對伊軍事打擊；美國5月CPI料重回「4字頭」
SpaceX上市倒計時！這7個ETF將第一時間納入，特斯拉被「合併」的可能性有多大？
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
